Cholesterol News and Research RSS Feed - Cholesterol News and Research

Cholesterol is a waxy, fat-like substance made in the liver, and found in the blood and in all cells of the body. Cholesterol is important for good health and is needed for making cell walls, tissues, hormones, vitamin D, and bile acid. Cholesterol also comes from eating foods taken from animals such as egg yolks, meat, and whole-milk dairy products. Too much cholesterol in the blood may build up in blood vessel walls, block blood flow to tissues and organs, and increase the risk of developing heart disease and stroke.
Rite Aid announces acquisition of Health Dialog Services

Rite Aid announces acquisition of Health Dialog Services

Rite Aid Corporation announced today it has acquired Boston-based Health Dialog Services Corporation, a leading provider of health coaching, shared decision making and healthcare analytics from Bupa, a London-based international healthcare services group. Through the acquisition, Health Dialog will operate as a wholly owned subsidiary of Rite Aid. Details of the transaction were not disclosed. [More]
Health Diagnostic Laboratory opens My HDL Hub health centers to prevent major chronic diseases

Health Diagnostic Laboratory opens My HDL Hub health centers to prevent major chronic diseases

Health Diagnostic Laboratory, Inc. is taking the next step in its mission to detect, prevent and reverse major chronic disease such as heart disease and diabetes with the launch of My HDL Hub health centers. HDL, Inc.'s My HDL Hub is a place for individuals to receive comprehensive blood tests, gain lifestyle, nutrition and fitness guidance with the company's Clinical Health Consultants and relate to others in the community with common goals of becoming healthier. [More]

Research uncovers link between diet and blood cell markers of heart attack associated inflammation

New research further illuminates the heart-healthy benefits of the Mediterranean diet, tying the eating plan to lower levels of platelets and white blood cells, two markers of inflammation. Inflammation has an association with greater risk of heart attack and stroke. [More]
Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

Bariatric surgery more effective than intensive medical therapy for managing type 2 diabetes

​Gastric bypass and sleeve gastrectomy - two of the most commonly used bariatric surgeries - are more effective than intensive medical therapy alone when it comes to managing uncontrolled type 2 diabetes in overweight or obese patients after three years, according to research presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]

Men with long-term HIV infections at higher risk of developing plaque in their coronary arteries

Men with long-term HIV infections are at higher risk than uninfected men of developing plaque in their coronary arteries, regardless of their other risk factors for coronary artery disease, according to results of a study led by Johns Hopkins researchers. A report on the research appears in the April 1 issue of Annals of Internal Medicine. [More]
Young adults with cardiac risk factors have worse cognitive function in middle age

Young adults with cardiac risk factors have worse cognitive function in middle age

Young adults with such cardiac risk factors as high blood pressure and elevated glucose levels have significantly worse cognitive function in middle age, according to a new study by dementia researchers at UC San Francisco. [More]
Bariatric surgery patients report better quality of life

Bariatric surgery patients report better quality of life

A study by Cleveland Clinic researchers shows bariatric surgery is a highly effective and durable treatment for type 2 diabetes in obese patients, enabling nearly all surgical patients to be free of insulin and many to be free of all diabetic medications three years after surgery. [More]
Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen reports positive findings from AMG 145 Phase 3 studies in patients at risk for cardiovascular disease

Amgen (NASDAQ: AMGN) today announced new detailed data from three Phase 3 studies that showed treatment with its novel investigational cholesterol-lowering medication, evolocumab (AMG 145), resulted in a statistically significant reduction of 55-66 percent in low-density lipoprotein cholesterol (LDL-C) compared to placebo in patients with high cholesterol. [More]
Genetic markers could help predict heart attack in patients with heart disease

Genetic markers could help predict heart attack in patients with heart disease

Researchers at the Intermountain Medical Center Heart Institute in Salt Lake City have identified a biological process that may help physicians predict when someone with heart disease is likely to have a heart attack in the near future. [More]

Researchers quantify proportion of adults potentially affected by updated 2014 BP recommendations

Applying the updated 2014 blood pressure (BP) guideline to the U.S. population suggests that nearly 6 million adults are no longer classified as needing hypertension medication, and that an estimated 13.5 million adults would now be considered as having achieved goal blood pressure, primarily older adults, according to a JAMA study released online to coincide with the 2014 American College of Cardiology Scientific Sessions. [More]
Newly identified protein markers have potential to contribute to better understanding of heart disease

Newly identified protein markers have potential to contribute to better understanding of heart disease

Researchers at the Intermountain Medical Center Heart Institute in Murray, Utah, have discovered that elevated levels of two recently identified proteins in the body are inflammatory markers and indicators of the presence of cardiovascular disease. [More]
Study on effects of cholesterol-lowering medications on sexual health

Study on effects of cholesterol-lowering medications on sexual health

A new study is giving hope to older men who are concerned about the effects of cholesterol-lowering medications on their sexual health. [More]
Aleglitazar drug does not reduce risk of cardiovascular events in patients with type 2 diabetes

Aleglitazar drug does not reduce risk of cardiovascular events in patients with type 2 diabetes

Use of the drug aleglitazar, which has shown the ability to lower glucose levels and have favorable effects on cholesterol, did not reduce the risk of cardiovascular death, heart attack or stroke among patients with type 2 diabetes and recent heart attack or unstable angina, according to a JAMA study released online to coincide with presentation at the 2014 American College of Cardiology Scientific Sessions. [More]
Study: Adolescents with stronger muscles have lower risk of heart disease and diabetes

Study: Adolescents with stronger muscles have lower risk of heart disease and diabetes

Adolescents with stronger muscles have a lower risk of heart disease and diabetes, according to a new study that examined the influence of muscle strength in sixth grade boys and girls. [More]
Popular cholesterol-lowering drugs may offer added benefit for men with erectile dysfunction

Popular cholesterol-lowering drugs may offer added benefit for men with erectile dysfunction

​Statins are associated with a significant improvement in erectile function, a fact researchers hope will encourage men who need statins to reduce their risk of heart attack to take them, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]
Women who drink too many diet drinks a day more likely to have heart problems

Women who drink too many diet drinks a day more likely to have heart problems

It appears healthy postmenopausal women who drink two or more diet drinks a day may be more likely to have a heart attack, stroke or other cardiovascular problems, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]

Celiac disease people may have near two-fold increased risk of coronary artery disease

People with celiac disease may have a near two-fold increased risk of coronary artery disease compared with the general population, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]

Reversing erectile dysfunction possible with lifestyle changes

Men suffering from sexual dysfunction can be successful at reversing their problem, by focusing on lifestyle factors and not just relying on medication, according to research at the University of Adelaide. [More]

TV watching leads to excessive snacking, cardiovascular risk in middle school kids

Middle school kids who park themselves in front of the TV for two hours or more each day are more likely to consume junk food and have risk factors for cardiovascular disease, even compared to those who spend an equal amount of time on the computer or playing video games, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]
Women who have 4 or more live births more likely to show early signs of heart disease

Women who have 4 or more live births more likely to show early signs of heart disease

Women who give birth to four or more children are much more likely to have evidence of plaque in their heart or thickening of their arteries - early signs of cardiovascular disease - compared with those having fewer pregnancies, according to research to be presented at the American College of Cardiology's 63rd Annual Scientific Session. [More]